In a new job - March 10, 2016
New recruitment for TLA Immunotherapies
Swedish TLA Immunotherapies, which recently signed a develeopment and licensing deal with Ferring Pharmaceuticals, has recruited Annette Brus to further speed up their market launch. The company has developed a technical platform for immunological diseases and the new recruitment, Annette Brus, will be leading the clinical trials. She has been working within the pharmaceutical industry […]
In a new job - March 9, 2016
Robert Califf named FDA Deputy Commissioner for Medical Products
U.S. Food and Drug Administration Commissioner Margaret A. Hamburg, M.D., has appointed Robert Califf, M.D., a recognized global leader in cardiology, clinical research, and medical economics, as FDA Deputy Commissioner for Medical Products and Tobacco. In this position, Dr. Califf will provide executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics […]
In a new job - February 1, 2016
New CEO of Medicon Valley Alliance
The Medicon Valley Alliance board has decided to appoint acting CEO of Medicon Valley Alliance since June 2015, Petter Hartman, as new CEO. Petter Hartman came to Medicon Valley Alliance in 2014 as funding manager from a position as project consultant with the Interreg Secretariat and seven years of in depth experience with Danish-Swedish regional […]
In a new job - February 1, 2016
Dilaforette appoints new VP of Development
Dilaforette, a Karolinska Development portfolio company focused on treatments for patients with sickle-cell disease, announces the appointment of Lena Jendeberg as its new Vice President of Development. Lena Jendeberg joins Dilaforette from Swedish Orphan Biovitrum, where she was Global Program Director, Project & Portfolio Management and Strategic Operations from 2010. In this role she was […]
In a new job - January 28, 2016
Antaros Medical makes key appointments
Antaros Medical, a service provider in drug development using imaging, has made two key appointments, Klas Malmberg, as the Chief Medical Officer and Elisabeth Bolling-Sternevald, as the Chief Operating Officer. Klas Malmberg MD, PhD, FESC, is an experienced cardiologist, medical expert and senior lecturer with wide experience from both academic and pharmaceutical industry. Klas extensive merit list […]
In a new job - January 14, 2016
Birgitte Volck to leave Sobi for GSK
Swedish Orphan Biovitrum has announced that Birgitte Volck, M.D., Ph.D., Senior Vice President of Development and Chief Medical Officer (CMO) of Sobi, will leave the company to join the rare disease research group at GlaxoSmithKline as Head of R&D Rare Diseases. Birgitte will work through a six month notice period before leaving Sobi. “We thank Birgitte […]
